Cargando…
A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes
Gestational diabetes mellitus (GDM) affects 3–14% of pregnancies, with 20–50% of these women progressing to type 2 diabetes (T2D) within 5 years. This study sought to develop a metabolomics signature to predict the transition from GDM to T2D. A prospective cohort of 1,035 women with GDM pregnancy we...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001181/ https://www.ncbi.nlm.nih.gov/pubmed/27338739 http://dx.doi.org/10.2337/db15-1720 |
_version_ | 1782450424650924032 |
---|---|
author | Allalou, Amina Nalla, Amarnadh Prentice, Kacey J. Liu, Ying Zhang, Ming Dai, Feihan F. Ning, Xian Osborne, Lucy R. Cox, Brian J. Gunderson, Erica P. Wheeler, Michael B. |
author_facet | Allalou, Amina Nalla, Amarnadh Prentice, Kacey J. Liu, Ying Zhang, Ming Dai, Feihan F. Ning, Xian Osborne, Lucy R. Cox, Brian J. Gunderson, Erica P. Wheeler, Michael B. |
author_sort | Allalou, Amina |
collection | PubMed |
description | Gestational diabetes mellitus (GDM) affects 3–14% of pregnancies, with 20–50% of these women progressing to type 2 diabetes (T2D) within 5 years. This study sought to develop a metabolomics signature to predict the transition from GDM to T2D. A prospective cohort of 1,035 women with GDM pregnancy were enrolled at 6–9 weeks postpartum (baseline) and were screened for T2D annually for 2 years. Of 1,010 women without T2D at baseline, 113 progressed to T2D within 2 years. T2D developed in another 17 women between 2 and 4 years. A nested case-control design used 122 incident case patients matched to non–case patients by age, prepregnancy BMI, and race/ethnicity. We conducted metabolomics with baseline fasting plasma and identified 21 metabolites that significantly differed by incident T2D status. Machine learning optimization resulted in a decision tree modeling that predicted T2D incidence with a discriminative power of 83.0% in the training set and 76.9% in an independent testing set, which is far superior to measuring fasting plasma glucose levels alone. The American Diabetes Association recommends T2D screening in the early postpartum period via oral glucose tolerance testing after GDM, which is a time-consuming and inconvenient procedure. Our metabolomics signature predicted T2D incidence from a single fasting blood sample. This study represents the first metabolomics study of the transition from GDM to T2D validated in an independent testing set, facilitating early interventions. |
format | Online Article Text |
id | pubmed-5001181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-50011812017-09-01 A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes Allalou, Amina Nalla, Amarnadh Prentice, Kacey J. Liu, Ying Zhang, Ming Dai, Feihan F. Ning, Xian Osborne, Lucy R. Cox, Brian J. Gunderson, Erica P. Wheeler, Michael B. Diabetes Metabolism Gestational diabetes mellitus (GDM) affects 3–14% of pregnancies, with 20–50% of these women progressing to type 2 diabetes (T2D) within 5 years. This study sought to develop a metabolomics signature to predict the transition from GDM to T2D. A prospective cohort of 1,035 women with GDM pregnancy were enrolled at 6–9 weeks postpartum (baseline) and were screened for T2D annually for 2 years. Of 1,010 women without T2D at baseline, 113 progressed to T2D within 2 years. T2D developed in another 17 women between 2 and 4 years. A nested case-control design used 122 incident case patients matched to non–case patients by age, prepregnancy BMI, and race/ethnicity. We conducted metabolomics with baseline fasting plasma and identified 21 metabolites that significantly differed by incident T2D status. Machine learning optimization resulted in a decision tree modeling that predicted T2D incidence with a discriminative power of 83.0% in the training set and 76.9% in an independent testing set, which is far superior to measuring fasting plasma glucose levels alone. The American Diabetes Association recommends T2D screening in the early postpartum period via oral glucose tolerance testing after GDM, which is a time-consuming and inconvenient procedure. Our metabolomics signature predicted T2D incidence from a single fasting blood sample. This study represents the first metabolomics study of the transition from GDM to T2D validated in an independent testing set, facilitating early interventions. American Diabetes Association 2016-09 2016-06-20 /pmc/articles/PMC5001181/ /pubmed/27338739 http://dx.doi.org/10.2337/db15-1720 Text en © 2016 by the American Diabetes Association. http://diabetesjournals.org/site/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://diabetesjournals.org/site/license. |
spellingShingle | Metabolism Allalou, Amina Nalla, Amarnadh Prentice, Kacey J. Liu, Ying Zhang, Ming Dai, Feihan F. Ning, Xian Osborne, Lucy R. Cox, Brian J. Gunderson, Erica P. Wheeler, Michael B. A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title | A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title_full | A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title_fullStr | A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title_full_unstemmed | A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title_short | A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes |
title_sort | predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes |
topic | Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001181/ https://www.ncbi.nlm.nih.gov/pubmed/27338739 http://dx.doi.org/10.2337/db15-1720 |
work_keys_str_mv | AT allalouamina apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT nallaamarnadh apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT prenticekaceyj apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT liuying apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT zhangming apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT daifeihanf apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT ningxian apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT osbornelucyr apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT coxbrianj apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT gundersonericap apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT wheelermichaelb apredictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT allalouamina predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT nallaamarnadh predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT prenticekaceyj predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT liuying predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT zhangming predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT daifeihanf predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT ningxian predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT osbornelucyr predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT coxbrianj predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT gundersonericap predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes AT wheelermichaelb predictivemetabolicsignatureforthetransitionfromgestationaldiabetesmellitustotype2diabetes |